
China Biologic Products Holdings Inc – NASDAQ:CBPO
China Biologic Products Holdings stock price today
China Biologic Products Holdings stock price monthly change
China Biologic Products Holdings stock price quarterly change
China Biologic Products Holdings stock price yearly change
China Biologic Products Holdings key metrics
Market Cap | 37.06M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 3.95 |
Revenue | 524.36M |
EBITDA | 215.54M |
Income | 152.28M |
Revenue Q/Q | 9.75% |
Revenue Y/Y | 4.09% |
Profit margin | 29.04% |
Oper. margin | 37.26% |
Gross margin | 65.68% |
EBIT margin | 37.26% |
EBITDA margin | 41.11% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeChina Biologic Products Holdings stock price history
China Biologic Products Holdings stock forecast
China Biologic Products Holdings financial statements
Mar 2020 | 162.59M | 53.38M | 32.83% |
---|---|---|---|
Jun 2020 | 111.11M | 35.68M | 32.11% |
Sep 2020 | 138.53M | 39.54M | 28.54% |
Dec 2020 | 112.12M | 23.67M | 21.11% |
2020-05-20 | 1.38 | 1.56 |
---|---|---|
2020-08-17 | 1.28 | 1.11 |
2020-11-24 | 1.28 | 1.39 |
2021-03-29 | 0.69 | 0.91 |
Mar 2020 | 1984725699 | 174.25M | 8.78% |
---|---|---|---|
Jun 2020 | 2024424491 | 165.33M | 8.17% |
Sep 2020 | 2139512852 | 163.82M | 7.66% |
Dec 2020 | 2259514231 | 177.73M | 7.87% |
Mar 2020 | 75.74M | -113.44M | 0 |
---|---|---|---|
Jun 2020 | 59.72M | 369.49M | -7.00M |
Sep 2020 | 53.02M | -27.76M | -4.98M |
Dec 2020 | 69.98M | 34.72M | -81.02K |
China Biologic Products Holdings other data
Period | Buy | Sel |
---|---|---|
Jun 2016 | 0 | 5550000 |
Aug 2016 | 0 | 54694 |
Feb 2017 | 0 | 62604 |
Mar 2017 | 0 | 74049 |
May 2017 | 0 | 7500 |
Quarter | Transcript |
---|---|
Q3 2020 25 Nov 2020 | Q3 2020 Earnings Call Transcript |
Q2 2020 18 Aug 2020 | Q2 2020 Earnings Call Transcript |
Q1 2020 21 May 2020 | Q1 2020 Earnings Call Transcript |
Q4 2019 13 Mar 2020 | Q4 2019 Earnings Call Transcript |
-
What's the price of China Biologic Products Holdings stock today?
One share of China Biologic Products Holdings stock can currently be purchased for approximately $119.99.
-
When is China Biologic Products Holdings's next earnings date?
Unfortunately, China Biologic Products Holdings's (CBPO) next earnings date is currently unknown.
-
Does China Biologic Products Holdings pay dividends?
No, China Biologic Products Holdings does not pay dividends.
-
How much money does China Biologic Products Holdings make?
China Biologic Products Holdings has a market capitalization of 37.06M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.09% to 524.37M US dollars. China Biologic Products Holdings earned 152.29M US dollars in net income (profit) last year or $0.91 on an earnings per share basis.
-
What is China Biologic Products Holdings's stock symbol?
China Biologic Products Holdings Inc is traded on the NASDAQ under the ticker symbol "CBPO".
-
What is China Biologic Products Holdings's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of China Biologic Products Holdings?
Shares of China Biologic Products Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does China Biologic Products Holdings have?
China Biologic Products Holdings Inc employs 2,246 workers.
-
When China Biologic Products Holdings went public?
China Biologic Products Holdings Inc is publicly traded company for more then 19 years since IPO on 24 Jul 2006.
-
What is China Biologic Products Holdings's official website?
The official website for China Biologic Products Holdings is chinabiologic.com.
-
How can i contact China Biologic Products Holdings?
China Biologic Products Holdings can be reached via phone at +86 10 6598 3111.
China Biologic Products Holdings company profile:

China Biologic Products Holdings Inc
chinabiologic.comNASDAQ
2,246
Biotechnology
Healthcare
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People's Republic of China. It offers human albumin for treating shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also provides human immunoglobulin and IVIG for original and secondary immunoglobulin deficiency, auto-immune deficiency, and immunoglobulin G secondary deficiency; human hepatitis B immunoglobulin for the prevention of measles and contagious hepatitis; human rabies immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; and human tetanus immunoglobulin for the prevention and therapy of tetanus. In addition, it offers placenta polypeptide for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia, as well as assists in postoperative healing; factor VIII for treating coagulopathies; human fibrinogen; and human prothrombin complex concentrate for treating congenital and acquired clotting factor II, VII, IX, X deficiency, as well as excessive anticoagulant, vitamin K deficiency, etc. Further, the company is developing Human fibrinogen for the treatment for lack of fibrinogen and increase human fibrinogen concentration; and artificial dura and spinal dura mater products for use in brain and spinal surgeries. The company sells its products directly, as well as through distributors. The company was formerly known as China Biologic Products, Inc. and changed its name to China Biologic Products Holdings, Inc. in July 2017. China Biologic Products Holdings, Inc. is headquartered in Beijing, the People's Republic of China.
Beijing, BEIJING 100125
CIK: 0001369868
ISIN: KYG215151047
CUSIP: G21515104